These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35502206)

  • 1. Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules.
    Nersisyan S; Zhiyanov A; Zakharova M; Ishina I; Kurbatskaia I; Mamedov A; Galatenko A; Shkurnikov M; Gabibov A; Tonevitsky A
    PeerJ; 2022; 10():e13354. PubMed ID: 35502206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1-BA.5 Peptides by HLA Molecules.
    Nersisyan SA; Shkurnikov MY; Zhiyanov AP; Novosad VO; Tonevitsky AG
    Dokl Biochem Biophys; 2022 Dec; 507(1):298-301. PubMed ID: 36786990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron.
    Chen LC; Nersisyan S; Wu CJ; Chang CM; Tonevitsky A; Guo CL; Chang WC
    J Autoimmun; 2022 Dec; 133():102952. PubMed ID: 36427410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations.
    Nersisyan S; Zhiyanov A; Shkurnikov M; Tonevitsky A
    Nucleic Acids Res; 2022 Jan; 50(D1):D883-D887. PubMed ID: 34396391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity.
    Yajima Y; Kosaka A; Ohkuri T; Hirohashi Y; Li D; Nagasaki T; Nagato T; Torigoe T; Kobayashi H
    Heliyon; 2023 Sep; 9(9):e20192. PubMed ID: 37809871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern.
    López D
    Front Immunol; 2022; 13():832889. PubMed ID: 35154154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of SARS-CoV-2-specific CD4
    Brand M; Keşmir C
    Immunogenetics; 2023 Jun; 75(3):283-293. PubMed ID: 36719467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
    Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
    Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.
    Parn S; Savsani K; Dakshanamurthy S
    Immunoinformatics (Amst); 2022 Dec; 8():100020. PubMed ID: 36337685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
    Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
    J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike.
    Wnuk K; Sudol J; Spilman P; Soon-Shiong P
    Front Immunol; 2022; 13():918928. PubMed ID: 35812370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
    Hikichi T; Sakamoto M; Harada M; Saito M; Yamane Y; Tokumura K; Nakamura Y
    J Hum Genet; 2022 Jul; 67(7):411-419. PubMed ID: 35110673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of CD8
    Swaminathan S; Lineburg KE; Panikkar A; Raju J; Murdolo LD; Szeto C; Crooks P; Le Texier L; Rehan S; Dewar-Oldis MJ; Barnard PJ; Ambalathingal GR; Neller MA; Short KR; Gras S; Khanna R; Smith C
    Nat Commun; 2022 Oct; 13(1):6387. PubMed ID: 36302758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition.
    Motozono C; Toyoda M; Tan TS; Hamana H; Goto Y; Aritsu Y; Miyashita Y; Oshiumi H; Nakamura K; Okada S; Udaka K; Kitamatsu M; Kishi H; Ueno T
    Nat Commun; 2022 Sep; 13(1):5440. PubMed ID: 36130929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
    Arora P; Zhang L; Rocha C; Graichen L; Nehlmeier I; Kempf A; Cossmann A; Ramos GM; Baier E; Tampe B; Moerer O; Dickel S; Winkler MS; Behrens GMN; Pöhlmann S; Hoffmann M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.